Published in Dig Dis Sci on January 11, 2015
Use of proteomic patterns in serum to identify ovarian cancer. Lancet (2002) 16.38
Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology (2001) 5.80
An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology (1993) 5.41
Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology (2000) 4.74
Feature extraction and quantification for mass spectrometry in biomedical applications using the mean spectrum. Bioinformatics (2005) 4.26
Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1997) 4.09
Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data. Bioinformatics (2003) 3.78
Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1998) 3.66
Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: a population-based study with temporal trends. Am J Gastroenterol (2009) 3.04
A perfect smoother. Anal Chem (2003) 2.97
Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis (2000) 2.36
A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol (2007) 2.31
Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. Gut (1991) 2.29
Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gastroenterol (1997) 2.23
Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Anal Chem (2004) 2.07
Parametric time warping. Anal Chem (2004) 2.00
Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc (1999) 1.90
Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis. Proc Natl Acad Sci U S A (2003) 1.75
Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones. Clin Biochem (2001) 1.51
Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention. Carcinogenesis (2001) 1.45
How large a training set is needed to develop a classifier for microarray data? Clin Cancer Res (2008) 1.38
Molecular biology of esophageal cancer. Onkologie (2004) 1.28
Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: identification of key issues affecting potential clinical utility. Cancer Res (2003) 1.26
Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology. Clin Chem (2005) 1.25
Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display. Proteomics (2005) 1.18
Rapid discovery and identification of a tissue-specific tumor biomarker from 39 human cancer cell lines using the SELDI ProteinChip platform. Biochem Biophys Res Commun (2003) 1.13
Urinary biomarker profiling in transitional cell carcinoma. Int J Cancer (2006) 1.12
Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: clinical applications. JAMA (2002) 1.11
Analysis of microdissected prostate tissue with ProteinChip arrays--a way to new insights into carcinogenesis and to diagnostic tools. Int J Mol Med (2002) 1.11
Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease. Cancer Res (2001) 1.10
A wide range of protein isoforms in serum and plasma uncovered by a quantitative intact protein analysis system. Proteomics (2005) 1.08
Amyloid beta peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease. Biol Psychiatry (2004) 1.01
The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma. Cancer Epidemiol Biomarkers Prev (2005) 1.00
Gene expression profiles in esophageal adenocarcinoma. Ann Thorac Surg (2004) 0.98
A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus. Oncogene (2004) 0.97
Accurate discrimination of Barrett's esophagus and esophageal adenocarcinoma using a quantitative three-tiered algorithm and multimarker real-time reverse transcription-PCR. Clin Cancer Res (2005) 0.90
Cellular distribution of the potassium channel KCNQ1 in normal mouse kidney. Am J Physiol Renal Physiol (2006) 0.90
Trends in esophageal cancer mortality among US blacks and whites. Am J Public Health (1987) 0.88
Preanalytical impact of sample handling on proteome profiling experiments with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem (2005) 0.88
Detection of prostate cancer using serum proteomics pattern in a histologically confirmed population. J Urol (2004) 0.87
The ProteinChip Biomarker System from Ciphergen Biosystems: a novel proteomics platform for rapid biomarker discovery and validation. Biochem Soc Trans (2002) 0.86
Association of COX-2 expression with corresponding active and chronic inflammatory reactions in Barrett's metaplasia and progression to cancer. Histopathology (2007) 0.81
Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med (2009) 10.91
A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med (2012) 4.51
A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc (2010) 4.26
Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. Gastroenterology (2011) 3.44
Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc (2009) 3.30
Effect of simply recording colonoscopy withdrawal time on polyp and adenoma detection rates. Gastrointest Endosc (2010) 2.89
Infection after ERCP, and antibiotic prophylaxis: a sequential quality-improvement approach over 11 years. Gastrointest Endosc (2007) 2.68
EUS-based criteria for the diagnosis of chronic pancreatitis: the Rosemont classification. Gastrointest Endosc (2009) 2.32
An analysis of multiple staging management strategies for carcinoma of the esophagus: computed tomography, endoscopic ultrasound, positron emission tomography, and thoracoscopy/laparoscopy. Ann Thorac Surg (2002) 1.80
The geography of power: statistical performance of tests of clusters and clustering in heterogeneous populations. Stat Med (2006) 1.77
Cost-effectiveness of computerized tomographic colonography versus colonoscopy for colorectal cancer screening. CMAJ (2005) 1.75
Diagnostic performance of EUS for chronic pancreatitis: a comparison with histopathology. Gastrointest Endosc (2007) 1.70
Multisociety guideline on reprocessing flexible gastrointestinal endoscopes: 2011. Gastrointest Endosc (2011) 1.69
Statistical analysis of relative labeled mass spectrometry data from complex samples using ANOVA. J Proteome Res (2008) 1.67
Endoscopic pancreatic sphincterotomy for pancreas divisum by using a needle-knife or standard pull-type technique: safety and reintervention rates. Gastrointest Endosc (2006) 1.66
Survival after bidirectional cavopulmonary anastomosis: analysis of preoperative risk factors. J Thorac Cardiovasc Surg (2007) 1.64
Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis. Nat Genet (2012) 1.63
Accurate molecular detection of non-small cell lung cancer metastases in mediastinal lymph nodes sampled by endoscopic ultrasound-guided needle aspiration. Chest (2005) 1.62
Interobserver agreement for EUS findings in familial pancreatic-cancer kindreds. Gastrointest Endosc (2007) 1.62
Accuracy of EUS in staging of T4 lung cancer. Gastrointest Endosc (2004) 1.60
Feasibility, safety, and effectiveness of transcranial direct current stimulation for decreasing post-ERCP pain: a randomized, sham-controlled, pilot study. Gastrointest Endosc (2011) 1.58
Influence of race and sex on prevalence and recurrence of colon polyps. Arch Intern Med (2010) 1.53
Chronic calcific pancreatitis: combination ERCP and extracorporeal shock wave lithotripsy for pancreatic duct stones. South Med J (2010) 1.52
Characterization of immunoisolated human gastric parietal cells tubulovesicles: identification of regulators of apical recycling. Am J Physiol Gastrointest Liver Physiol (2007) 1.49
Standardized endoscopic reporting. J Gastroenterol Hepatol (2014) 1.46
Detection of telomerase expression in mediastinal lymph nodes of patients with lung cancer. Am J Respir Crit Care Med (2003) 1.42
Grading the complexity of endoscopic procedures: results of an ASGE working party. Gastrointest Endosc (2011) 1.39
The relationship between health literacy and diabetes knowledge and readiness to take health actions. Diabetes Educ (2007) 1.37
Endoscopic ultrasound: a meta-analysis of test performance in suspected biliary obstruction. Clin Gastroenterol Hepatol (2007) 1.33
A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphoma. Blood (2009) 1.28
Diagnosis of benign cysts of the mediastinum: the role and risks of EUS and FNA. Gastrointest Endosc (2003) 1.25
A small fibronectin-mimicking protein from bacteria induces cell spreading and focal adhesion formation. J Biol Chem (2010) 1.19
Characteristics of symptomatic reflux episodes on Acid suppressive therapy. Am J Gastroenterol (2008) 1.14
PrepMS: TOF MS data graphical preprocessing tool. Bioinformatics (2006) 1.13
Predictors of early mortality after traumatic spinal cord injury: a population-based study. Spine (Phila Pa 1976) (2010) 1.13
Maternal-fetal medicine specialist density is inversely associated with maternal mortality ratios. Am J Obstet Gynecol (2005) 1.12
Accurate discrimination of pancreatic ductal adenocarcinoma and chronic pancreatitis using multimarker expression data and samples obtained by minimally invasive fine needle aspiration. Int J Cancer (2007) 1.12
Nonoperative imaging techniques in suspected biliary tract obstruction. HPB (Oxford) (2006) 1.12
Helicobacter pylori CagL activates ADAM17 to induce repression of the gastric H, K-ATPase alpha subunit. Gastroenterology (2010) 1.11
Racial disparities in advanced-stage colorectal cancer survival. Cancer Causes Control (2013) 1.10
EUS-guided fine needle aspiration of the liver: indications, yield, and safety based on an international survey of 167 cases. Gastrointest Endosc (2002) 1.10
Inappropriate use of intravenous pantoprazole: extent of the problem and successful solutions. Clin Gastroenterol Hepatol (2005) 1.10
Helicobacter pylori represses proton pump expression and inhibits acid secretion in human gastric mucosa. Gut (2010) 1.08
Endosonographic features predictive of malignancy in mediastinal lymph nodes in patients with lung cancer. Gastrointest Endosc (2010) 1.06
iQuantitator: a tool for protein expression inference using iTRAQ. BMC Bioinformatics (2009) 1.06
Accuracy of EUS criteria and primary tumor site for identification of mediastinal lymph node metastasis from non-small-cell lung cancer. Gastrointest Endosc (2004) 1.06
Physical and mental quality of life in chronic pancreatitis: a case-control study from the North American Pancreatitis Study 2 cohort. Pancreas (2013) 1.06
Secondhand smoke exposure in young people and parental rules against smoking at home and in the car. Public Health Rep (2011) 1.05
Verrucous carcinoma of the esophagus eluding multiple sets of endoscopic biopsies and endoscopic ultrasound: a case report and review of the literature. Can J Gastroenterol (2004) 1.04
Management of patients with nonvariceal upper gastrointestinal bleeding. Clin Gastroenterol Hepatol (2011) 1.03
Carbon nanoparticle-based fluorescent bioimaging probes. Sci Rep (2013) 1.02
Is routine second-look endoscopy effective after endoscopic hemostasis in acute peptic ulcer bleeding? A meta-analysis. Gastrointest Endosc (2012) 1.02
Violence and PTSD in Mexico: gender and regional differences. Soc Psychiatry Psychiatr Epidemiol (2005) 1.01
Radiation exposure time during MBSS: influence of swallowing impairment severity, medical diagnosis, clinician experience, and standardized protocol use. Dysphagia (2012) 1.00
Trends in survival of patients with Burkitt lymphoma/leukemia in the USA: an analysis of 3691 cases. Blood (2013) 1.00
Endoscopic ultrasound in lung cancer patients with a normal mediastinum on computed tomography. Ann Thorac Surg (2004) 0.99
EUS in patients with surgically altered upper GI anatomy. Gastrointest Endosc (2010) 0.99
Low symptomatic premature stent occlusion of multiple plastic stents for benign biliary strictures: comparing standard and prolonged stent change intervals. Gastrointest Endosc (2010) 0.98
Predictors of endoscopic findings after Roux-en-Y gastric bypass. Am J Gastroenterol (2006) 0.98
Helical CT versus EUS with fine needle aspiration for celiac nodal assessment in patients with esophageal cancer. Gastrointest Endosc (2002) 0.96
Does rectal indomethacin eliminate the need for prophylactic pancreatic stent placement in patients undergoing high-risk ERCP? Post hoc efficacy and cost-benefit analyses using prospective clinical trial data. Am J Gastroenterol (2013) 0.96
An introspective comparison of random forest-based classifiers for the analysis of cluster-correlated data by way of RF++. PLoS One (2009) 0.96
It is premature to conclude pancreatic sphincterotomy is not beneficial in idiopathic pancreatitis. Gastroenterology (2013) 0.95
Long-term clinical outcomes after endoscopic minor papilla therapy in symptomatic patients with pancreas divisum. Pancreas (2009) 0.95
Measuring episodic abdominal pain and disability in suspected sphincter of Oddi dysfunction. World J Gastroenterol (2010) 0.95
Canadian credentialing guidelines for endoscopic retrograde cholangiopancreatography. Can J Gastroenterol (2008) 0.94
Helicobacter pylori-induced H,K-ATPase alpha-subunit gene repression is mediated by NF-kappaB p50 homodimer promoter binding. Am J Physiol Gastrointest Liver Physiol (2008) 0.94
Maternal super-obesity (body mass index > or = 50) and adverse pregnancy outcomes. Acta Obstet Gynecol Scand (2010) 0.93
Joint spatial survival modeling for the age at diagnosis and the vital outcome of prostate cancer. Stat Med (2008) 0.92
Multisociety guideline on reprocessing flexible GI endoscopes: 2011. Infect Control Hosp Epidemiol (2011) 0.92
Detection of occult liver metastases during EUS for staging of malignancies. Gastrointest Endosc (2004) 0.92
Primary squamous cell carcinoma of pancreas diagnosed by EUS-FNA: a case report. World J Gastroenterol (2009) 0.92
Canadian credentialing guidelines for esophagogastroduodenoscopy. Can J Gastroenterol (2008) 0.92
Assessment of health state utilities and quality of life in patients with malignant esophageal Dysphagia. Am J Gastroenterol (2004) 0.91
Real-time reverse transcription-PCR detects KS1/4 mRNA in mediastinal lymph nodes from patients with non-small cell lung cancer. Clin Chem (2003) 0.91
Miss rate of pancreas divisum by magnetic resonance cholangiopancreatography in clinical practice. Pancreas (2008) 0.90
Challenges in planning and initiating a randomized clinical study of sphincter of Oddi dysfunction. Gastrointest Endosc (2010) 0.90
Accurate discrimination of Barrett's esophagus and esophageal adenocarcinoma using a quantitative three-tiered algorithm and multimarker real-time reverse transcription-PCR. Clin Cancer Res (2005) 0.90
Chromosomal anomalies influence parental treatment decisions in relation to prenatally diagnosed congenital heart disease. Pediatr Cardiol (2009) 0.90
Chick embryos exposed to trichloroethylene in an ex ovo culture model show selective defects in early endocardial cushion tissue formation. Birth Defects Res A Clin Mol Teratol (2006) 0.90
Cell cycle regulation of purine synthesis by phosphoribosyl pyrophosphate and inorganic phosphate. Biochem J (2013) 0.89
Cetuximab therapy for head and neck squamous cell carcinoma: a systematic review of the data. Otolaryngol Head Neck Surg (2011) 0.89
Parietal cell carcinoma of gastric cardia: immunophenotype and ultrastructure. Ultrastruct Pathol (2003) 0.88
Mind the gap: racial differences in breast cancer incidence and biologic phenotype, but not stage, among low-income women participating in a government-funded screening program. Breast Cancer Res Treat (2012) 0.87
A Bayesian hierarchical modeling approach for studying the factors affecting the stage at diagnosis of prostate cancer. Stat Med (2008) 0.87
IL-1beta modulation of H,K-ATPase alpha-subunit gene transcription in Helicobacter pylori infection. Am J Physiol Gastrointest Liver Physiol (2007) 0.87
Primary hepatic gastrinoma: an unusual case of zollinger-ellison syndrome. Gastroenterol Hepatol (N Y) (2010) 0.87
Formation of physically stable amorphous phase of ibuprofen by solid state milling with kaolin. Eur J Pharm Biopharm (2007) 0.87
Logic Forest: an ensemble classifier for discovering logical combinations of binary markers. Bioinformatics (2010) 0.87
Accuracy of EUS for detection of intraductal papillary mucinous tumor of the pancreas. Gastrointest Endosc (2002) 0.86
Prior surgery determines islet yield and insulin requirement in patients with chronic pancreatitis. Transplantation (2013) 0.86
Patterns of use of endoscopic retrograde cholangiopancreatography in a Canadian province. Can J Gastroenterol (2004) 0.85